Exon junction complexes regulate osteoclast‐induced bone resorption by influencing the NFATc1 m6A distribution through the “shield effect”
Open Access
- 6 March 2025
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 15 (3) , e70266
Abstract
Background: The distribution of the m6A methylation modification on the transcriptome is highly regionally selective and is mainly concentrated in abnormally long exons and stop codons. However, in‐depth research on the selective mechanism of m6A methylation is still lacking.Methods: In this research, meRIP sequencing, mRNA sequencing, meRIP, luciferase reporter assays and CRISPR/Cas9 conditional knockout mice were used to elucidate the distribution characteristics of NFATc1 m6A.Results: METTL14 controls osteoclast‐mediated bone resorption by means of the methylation (4249 A) of the NFATc1 gene during osteoclast differentiation. Exon junction complexes (EJCs) selectively protect the m6A methylation sites of the NFATc1 gene. When the methylation sites are located within short exon fragments (50–200 nt), EJCs prevent their hypermethylation and degradation through the “shield effect”; when the methylation sites are located in the 3′ UTR region or long exon fragments (greater than 300 nt), the “shield effect” disappears. Downstream, YTHDF2 induced the degradation of hypermethylation NFATc1 transcripts without site restriction.Conclusions: EJCs act as “shields” to regulate the m6A region selectivity of the NFATc1 gene, thereby determining the characteristics of m6A distribution in the gene. Importantly, EJCs can raise the level of m6A methylation of NFATc1 and degrade its mRNA, thereby inhibiting osteoclast differentiation and preserving bone mass. These results will be helpful for identifying potential molecular targets for osteoporosis treatment.Key points: METTL14 controls osteoclast‐mediated bone resorption by means of the methylation (4249 A) of the NFATc1 gene during osteoclast differentiation. Exon junction complexes (EJCs) protect the remaining methylation sites of the NFATc1 gene (located in the inner exon fragment of 50–200 nt) from hypermethylation and degradation. The “shield effect” disappears when the exon fragment is extended to 300 nt. Downstream, YTHDF2 induced the degradation of hypermethylation NFATc1 transcripts without site restriction.Keywords
Funding Information
- National Natural Science Foundation of China (82141108)
- Natural Science Foundation of Jiangsu Province (BK20201350)
This publication has 43 references indexed in Scilit:
- Projection of osteoporosis-related fractures and costs in China: 2010–2050Osteoporosis International, 2015
- N6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactionsNature, 2015
- An overview on the treatment of postmenopausal osteoporosisArchives of Endocrinology and Metabolism, 2014
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse FertilityMolecular Cell, 2013
- CLIP-seq of eIF4AIII reveals transcriptome-wide mapping of the human exon junction complexNature Structural & Molecular Biology, 2012
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in trabecular bone of ovariectomized ratsBone, 2011
- Osteoporosis: now and the futureThe Lancet, 2011
- Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein coreRNA, 2005